Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP(®) scale: prevalence, risk factors and the impact of therapeutic patient education.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY(2017)
Abstract
Atopic dermatitis (AD), is a chronic, inflammatory disease with a worldwide prevalence of 10 to 20% (1). Although topical corticosteroids (TCS) are known to be efficient and safe for the treatment of AD (2), there is a widespread fear about their use (topical corticosteroid phobia (TCSP)) in 40 to 73% of patients (3,4). TCSP represents the main cause of treatment failure. Until now, TCSP has been evaluated with a single binary question which is not adapted for this complex phenomenon. This article is protected by copyright. All rights reserved.
MoreTranslated text
Key words
Atopic dermatitis,corticosteroid phobia,therapeutic education,topical corticosteroid
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined